Skip to main content
Clinical Trials/NL-OMON48103
NL-OMON48103
Recruiting
Not Applicable

Cardiorespiratory fitness in newly diagnosed patients with Relapsing Remitting Multiple Sclerosis compared to matched healthy controls: already lagging behind from the start? - VO2max in early MS / LOW2early

Vrije Universiteit Medisch Centrum0 sites32 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Multiple Sclerosis (MS)
Sponsor
Vrije Universiteit Medisch Centrum
Enrollment
32
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • MS patients
  • In order to be eligible to participate in this study, the MS patients must meet all of the following criteria:
  • \- definite diagnosis of Relapsing Remitting MS according to the most recent international diagnostic criteria;
  • \- diagnosis within 12 months prior to inclusion date;
  • \- disease severity: EDSS score of maximal 2 with normal pyramidal and cerebellar functions (i.e. Functional Systems Score for pyramidal functions \= 0 and Functional Systems Score for cerebellar functions \= 0\).
  • \- age at definite diagnosis between 18\-65 years.
  • Healthy Siblings/Controls (controls)
  • In order to be eligible to participate in this study, the healthy controls must meet the following criteria:
  • \- healthy sibling of participant with MS, and matching with respect to sex, age (± 5 years), level of physical activity in the past year;
  • \- healthy persons, matching to MS participants with respect to sex, age (± 5 years), and level of physical activity in the past year.

Exclusion Criteria

  • \- Physician\-confirmed diagnosis of (other) neurological disorders or systemic or malignant neoplastic diseases.
  • \- Serious comorbidities precluding Cardiopulmonary Exercise test (CPET) or Lung function examination.
  • \- Use of heart rate regulating medication (e.g. Beta\-blockers).
  • \- Use of medication for lung diseases.
  • \- Being pregnant, or receiving medical help/fertility treatment to become pregnant.
  • \- Body Mass Index of 30 or higher.
  • \- Sports and exercise activities in the past year of \> 10 hours/week.
  • \- Does not speak Dutch.

Outcomes

Primary Outcomes

Not specified

Similar Trials